Evidence map›Paper›PMID 39535713›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2025

reCRAC: A Stringent Method for Precise Mapping of Protein-RNA Interactions in Yeast.

Michaela Ristová, Vadim Shchepachev, David Tollervey

Abstract read
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Michaela Ristová *Wellcome Centre for Cell Biology, University of Edinburgh, Edinburgh, UK. s1507601@ed.ac.uk.
Vadim Shchepachev *Wellcome Centre for Cell Biology, University of Edinburgh, Edinburgh, UK.
David TollerveyWellcome Centre for Cell Biology, University of Edinburgh, Edinburgh, UK. d.tollervey@ed.ac.uk.

Funding

Wellcome Trust 222516
6 · The paper itself

Abstract

Intricate interactions between RNA-binding proteins (RBPs) and RNA play pivotal roles in cellular homeostasis, impacting a spectrum of biological processes vital for survival. UV crosslinking methods to study protein-RNA interactions have been instrumental in elucidating their interactions but can be limited by degradation of target proteins during the process, low signal-to-noise ratios, and nonspecific interactions. Addressing these limitations, we describe reCRAC (reverse CRAC), a novel adaptation of the CRAC (crosslinking and analysis of cDNA) technique, optimized for yeast Saccharomyces cerevisiae. Like CRAC, reCRAC applies tandem affinity purification to yield highly enriched protein preparations. However, reCRAC is redesigned to work with unstable proteins. This is achieved by lysing the cells directly into highly denaturing buffer conditions, followed by stringent purification steps. The reCRAC method was successfully applied to the easily degraded yeast protein Pin4, allowing identification of precise binding sites at base-pair resolution with greatly reduced target protein degradation and improved signal-to-noise ratios.

Indexed as

RNA-Binding ProteinsSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsBinding SitesDNA, ComplementaryProtein BindingRNARNA, FungalTandem Affinity PurificationDNA, ComplementaryRNARNA-Binding ProteinsRNA, FungalSaccharomyces cerevisiae ProteinsCRAC (crosslinking and analysis of cDNA)Denaturing pulldown and purificationProtein–RNA interactionsreCRAC (reverse CRAC)Reduced protein degradationRNA-binding proteinsUV crosslinking

Identifiers

PMID39535713
PMCPMC7618710

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.